The Drug Enforcement Administration has proposed new regulations to give the public more options for disposing of unwanted prescription drugs, such as painkillers and sedatives.
Category results for "Prevention"
The U.S. Navy has released a video that demonstrates the disturbing effects of bath salts, ABC News reports. The video is the latest weapon in the Navy’s effort to combat synthetic drug use.
Registration is open for Community Anti-Drug Coalitions of America (CADCA)’s 23rd annual National Leadership Forum, to be held February 4-7 in National Harbor, Maryland. The CADCA Forum is the nation’s largest training conference for community prevention and treatment professionals and researchers.
Join Together has been the nation’s leader in providing free, high-quality addiction prevention and treatment information to communities nationwide for more than 20 years. Your loyal support ensures that we can continue to deliver this valuable service, but we need your help.
A task force of doctors, legislators and public health advocates in Florida are set to make recommendations to reduce the number of newborns exposed to opioids.
Now that recreational marijuana is legal in Colorado and Washington, employers in those states must determine how to handle employees who fail a drug test after using the drug on their own time.
Florida Attorney General Pam Bondi signed an emergency rule this week that outlaws 22 new synthetic drugs. The outlawed drugs are various forms of baths salts, or synthetic marijuana, known as K2 or Spice, according to the Orlando Sentinel.
New government guidelines recommend primary care doctors counsel children and teens not to start smoking. The U.S. Preventive Services Task Force concluded that prevention is more effective than trying to get youth to stop smoking once they’ve started.
A Kentucky law that requires anyone writing a prescription for a controlled substance to check the state drug monitoring database has led to the discovery that some people addicted to opioids are targeting dentists.
A panel of experts assembled by the U.S. Food and Drug Administration voted against recommending approval of the painkiller Zohydro ER on Friday. The panel cited concerns over the potential for addiction.